| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 115,273 | 119,478 | 111,158 | 111,836 | | Cost of Revenue | 14,941 | 15,294 | 15,170 | 10,807 | | | Gross Profit | 100,332 | 104,184 | 95,988 | 101,029 | | | Operating Expenses | | Research Development | 23,687 | 23,009 | 23,024 | 22,542 | | Selling General and Administrative | 34,128 | 32,248 | 32,131 | 29,540 | | Non Recurring |
-
| 45,648 | 7,971 |
-
| | Others | 25,208 | 24,885 | 24,808 | 23,374 | | | | Total Operating Expenses |
-
| 125,790 | 87,934 |
-
| | | | Operating Income or Loss | 17,309 | (21,606) | 8,054 | 25,573 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,814) | 1,370 | 1,455 | 1,236 | | Earnings Before Interest And Taxes | 9,495 | (20,236) | 9,509 | 26,809 | | Interest Expense | 10,266 | 13,589 | 17,578 | 16,963 | | Income Before Tax | (771) | (33,825) | (8,069) | 9,846 | | Income Tax Expense | 11,150 | (31,854) | (2,724) | (3,017) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,921) | (1,971) | (5,345) | 12,863 | | | Non-recurring Events | | Discontinued Operations |
-
| (171) | (36,170) | (222,747) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (11,921) | (2,142) | (41,515) | (209,884) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,921) | ($2,142) | ($41,515) | ($209,884) |
|
1.48% Nasdaq 
Income Statement
